Stocks360

LAVA Medtech Acquisition Corp. (LVAC)

Stock analysis · NASDAQ · Financial Services · Shell Companies

Share: Facebook X WhatsApp SMS
$10.43

Get deeper signals and personalized alerts

Free account signup in under 60 seconds

Create free account → I already have an account
Market Cap
$149.93M
PE (TTM)
33.65
EPS (TTM)
N/A
Dividend Yield
0.00%
Beta
0.00
Day Range
$10.42 – $10.44
52-wk Range
$9.94 – $10.85
Avg Volume
N/A
Volume
0.00

LAVA Medtech Acquisition Corp. (LVAC) is a publicly traded company in the Financial Services sector. Latest price: $10.43. Market cap $149.93M. Trailing PE 33.65. Sign in to Stocks360 for full DCF valuation, fundamentals, technicals, and AI-driven analysis.

Get full analysis → Short-Term Analysis →

Proprietary Signals

Signal snapshot temporarily unavailable.

About LAVA Medtech Acquisition Corp.

LAVA Medtech Acquisition Corp. (LVAC) currently lacks significant standalone operations. Its primary objective is to secure businesses or assets through various strategic transactions, including mergers, capital stock exchanges, asset acquisitions, stock purchases, or corporate reorganizations. The firm's strategic focus is directed towards opportunities within the healthcare and allied industries. Established in 2021, the company is based in Waltham, Massachusetts, and operates as a subsidiary of LAVA Medtech Sponsor LP.

Valuation

Trailing twelve months. Multiples relative to current market price.
P/E (TTM)33.65×
P/S (TTM)0.00×
P/B1.29×
P/FCF (TTM)-227.57×
EV / EBITDA-95.31×
EV / Sales0.00×
Earnings Yield3.00%
Free Cash Flow Yield-0.44%

Fundamentals

Trailing twelve months. Source: financial statements via market data.
Enterprise Value$148.77M
Net Income (TTM)$4.50M
Free Cash Flow (TTM)-$658.82K
Net Debt-$1.16M
Working Capital-$3.39M
Gross Margin0.00%
Operating Margin0.00%
Net Margin0.00%
Return on Equity3.96%
Return on Invested Capital-1.26%

Peers

Recent News

  • No recent news available.

Related

Browse more tickers: sitemap